Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ocumension Therapeutics (HK:1477)
HKEX:1477
Ocumension Therapeutics (1477) Stock Price & Analysis
1 Followers
1477 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$4.51 - HK$10.40
Previous CloseHK$6.85
Volume581.00K
Average Volume (3M)892.11K
Market Cap
HK$4.62B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Aug 23, 2024EPS Estimate
-HK$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding695,614,850
10 Day Avg. Volume226,837
30 Day Avg. Volume892,110
Standard Deviation0.16
R-Squared0.55
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ocumension Therapeutics News
PremiumCompany Announcements
Ocumension Therapeutics Shareholders Approve All Resolutions
PremiumCompany Announcements
Ocumension Therapeutics Sets Key AGM DateOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
4.97% Mutual Funds
1.44% Other Institutional Investors
93.59% Public Companies and
Individual Investors
1477 FAQ
What was Ocumension Therapeutics’s price range in the past 12 months?
Ocumension Therapeutics lowest stock price was HK$4.51 and its highest was HK$10.40 in the past 12 months.
What is Ocumension Therapeutics’s market cap?
Currently, no data Available
When is Ocumension Therapeutics’s upcoming earnings report date?
Ocumension Therapeutics’s upcoming earnings report date is Aug 23, 2024 which is in 52 days.
How were Ocumension Therapeutics’s earnings last quarter?
Ocumension Therapeutics released its earnings results on Mar 21, 2024. The company reported -HK$0.29 earnings per share for the quarter, beating the consensus estimate of -HK$0.301 by HK$0.011.
Is Ocumension Therapeutics overvalued?
According to Wall Street analysts Ocumension Therapeutics’s price is currently Overvalued.
Does Ocumension Therapeutics pay dividends?
Ocumension Therapeutics does not currently pay dividends.
What is Ocumension Therapeutics’s EPS estimate?
Ocumension Therapeutics’s EPS estimate is -HK$0.23.
How many shares outstanding does Ocumension Therapeutics have?
Ocumension Therapeutics has 693,654,850 shares outstanding.
What happened to Ocumension Therapeutics’s price movement after its last earnings report?
Ocumension Therapeutics reported an EPS of -HK$0.29 in its last earnings report, beating expectations of -HK$0.301. Following the earnings report the stock price went up 3.821%.
Which hedge fund is a major shareholder of Ocumension Therapeutics?
Currently, no hedge funds are holding shares in HK:1477
---
Ocumension Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.73%
12-Months-Change
Fundamentals
Return on Equity
-13.36%
Trailing 12-Months
Asset Growth
5.39%
Trailing 12-Months
Company Description
Ocumension Therapeutics
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.
---
1477 Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 1477
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-16.17%
reiterated a buy rating 3 months ago
Copying Ziyi Chen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -16.17% per trade.
---